Grant Awards in April & October 2007
Preface >>
Facts and Figures >>
| Principal Investigator | Project Title/Link |
| 1. Grant Awards in Cycle XVII & XVIII | |
| 1.1 Conventional ROTRF Research Grants - Cycle XVII | |
|
Dr Reza Abdi Brigham and Women's Hospital, Boston, USA |
The Role of Donor Dendritic Cells in Promotion of Tolerance |
|
Dr David M. Briscoe Children’s Hospital Boston, Boston, USA |
The Role of the Vasculature in Transplant Rejection or Long-term Transplant Survival |
|
Dr Donna L. Farber University of Maryland School of Medicine, Baltimore, USA |
The Role of Memory T Cells in Transplant Rejection |
|
Dr Franck Halary Université de Nantes, Nantes, France |
Study of Cytomegalovirus/dendritic Cells Interplays in Kidney Transplantation |
|
Dr Angus W. Thomson University of Pittsburgh, Pittsburgh, USA |
Regulation of Immune Responses in the Liver and Following Liver Transplantation |
| 1.2 Conventional ROTRF Research Grants - Cycle XVIII | |
|
Dr Patrick Bertolino University of Sydney, Sydney, Australia |
Understanding Unique Properties of Liver Transplants to Prolong the Survivalof All Other Organ Transplants |
|
Dr Anita Chong The University of Chicago, Chicago, USA |
Bacterial Infections and Transplantation Tolerance |
|
Dr Anatolij Horuzsko Medical College of Georgia, Augusta, USA |
Improvement of Allograft Survival by Special Forms of HLA-G and Inhibitory Receptor |
|
Dr Alain Le Moine Université Libre de Bruxelles, Bruxelles, Belgium |
Impact of IL-17 Producing T Cells on Long-term and Short-term Allograft Survival |
|
Dr Johannes Lisman University Medical Centre Groningen, Groningen, The Netherlands |
Do Blood Platelets Affect Quality of Organs to be Transplanted from a Brain-Dead Organ Donor? |
|
Dr Joren C. Madsen Massachusetts General Hospital, Boston, USA |
How the Innate and Adaptive Immune Systems Interact to Prevent Long-term Allograft Survival |
|
Dr Lorna Marson University of Edinburgh, Edinburgh, UK |
Lymph Vessels in Kidney Transplantation |
| 1.3 Clinical ROTRF Research Grants - Cycle XVII | |
|
Prof. John Andrew Kirby University of Newcastle, Newcastle-upon-Tyne, UK |
Examination of Bile Duct Changes after Liver Transplantation |
|
Dr Richard S. Mangus Indiana University, Indianapolis, USA |
Use of Extended Criteria Donor Organs in Liver Transplantation |
|
Dr Alberto Sanchez-Fueyo Hospital Clinic Barcelona, Barcelona, Spain |
Impact of Hepatitis C Virus Infection on the Acquisition of Tolerance after Liver Transplantation |
| 1.4 Clinical ROTRF Research Grants - Cycle XVIII | |
|
Dr Banu Sis University of Alberta, Alberta, Canada |
The Transcriptome of Antibody-mediated Rejection in Human Renal Allografts |
|
Prof. Kathryn J. Wood University of Oxford, Oxford, UK |
Immune Regulation in Transplant Recipients with and without Skin Cancer |
| 2. ROTRF/JDRF Joint Grant Awards - Cycle XVII & XVIII | |
| 2.1 Conventional ROTRF/JDRF Joint Grant Awards - Cycle XVII | |
|
Dr Jane H. Buckner Benaroya Research Institute, Seattle, USA |
Induction of Minor Histocompatibility Specific T Regulatory Cells as a Therapy of Transplant Rejection |
| 2.2 Conventional ROTRF/JDRF Joint Grant Awards - Cycle XVIII | |
|
Dr Megan Levings University of British Columbia, Vancouver, Canada |
Using Cells to Prevent the Rejection of Transplanted Organs |
|
Dr Jon Odorico University of Wisconsin, Madison, USA |
Immune Responses to Human Pancreatic Progenitor Cells |
| 2.3 Clinical ROTRF/JDRF Joint Grant Awards - Cycle XVII | |
|
Dr Mark Howard Siegelman University of Texas Southwestern Medical Center, Dallas, USA |
Use of a Unique Marker to Identify Cells that can Control Transplant Rejection |
